Distro — Free Sales Engagement Platform
Sequences, cloud call center, shared inbox, form tracking and more — on a single platform. Double your sales team's output with fewer tools.
Create a sequence — it's free
South African Tuberculosis Vaccine Initiative (Satvi)
the south african tuberculosis vaccine initiative (satvi) is a tuberculosis research group with a research focus that spans several disciplines including paediatrics, infectious diseases, epidemiology, public health, immunology, systems biology and clinical sciences. satvi has a large and well-developed clinical field site in the boland overberg region, with the core on the premises of the brewelskloof tb hospital in worcester, from where most clinical/epidemiological studies and clinical trials of new tb vaccines are conducted. the immunology and laboratory based work is led by associate professor tom scriba; and the clinical trials work is led by satvi director, associate professor mark hatherill.
Frequently asked questions about South African Tuberculosis Vaccine Initiative (Satvi)
Let us help answer the most common questions you might have.
Where is South African Tuberculosis Vaccine Initiative (Satvi) located?
South African Tuberculosis Vaccine Initiative (Satvi)'s headquarters is located at Cape Town, Western Cape, South Africa
How many employees does South African Tuberculosis Vaccine Initiative (Satvi) have?
South African Tuberculosis Vaccine Initiative (Satvi) has 35 employees
What industry does South African Tuberculosis Vaccine Initiative (Satvi) belong to?
South African Tuberculosis Vaccine Initiative (Satvi) is in the industry of: Research
What are South African Tuberculosis Vaccine Initiative (Satvi)'s social media links?
South African Tuberculosis Vaccine Initiative (Satvi) Linkedin page
Distro — Free Sales Engagement Platform
Sequences, cloud call center, shared inbox, form tracking and more — on a single platform. Double your sales team's output with fewer tools.
Create a sequence — it's free